Skip to content

Characterization of the iridocorneal angle in humans in vivo using OCT gonioscopy.

Characterization of the iridocorneal angle in humans in vivo using OCT gonioscopy.

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00033946
Enrollment
200
Registered
2025-09-16
Start date
2024-06-01
Completion date
Unknown
Last updated
2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

H40.1

Interventions

Group 1: 100 healthy subjects - This group consists of subjects without glaucoma and serves as a control group to study normal conditions of the trabecular meshwork (TM), Schlemm canal (SC) and adjace

Sponsors

Universitätsklinikum Bonn
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Presence of informed consent, a spherical equivalent < 3 Dpt, and no other ophthalmologic concomitant diseases

Exclusion criteria

Exclusion criteria: Non-consenting adults; persons in closed facilities / in prison

Design outcomes

Primary

MeasureTime frame
Image quality of the OCT volume scans of the TM - evaluation of the clarity and accuracy of the images produced by the OCT devices.

Secondary

MeasureTime frame
Ability to visualize the Schlemm's canal (SC) and detect any narrowing in glaucoma - Evaluate the effectiveness of OCT technology in visualizing the SC and identifying changes associated with glaucoma. Comparison of the iridocorneal angle (ICA) between healthy subjects and glaucoma patients - Investigate for differences or specific characteristics that occur in glaucoma patients compared to healthy individuals. Detailed characterization of the TM and SC in vivo - using the knowledge gained from the OCT scans to develop a deeper understanding of the structure and function of these areas of the eye under both normal and pathological conditions.

Countries

Germany

Contacts

Public ContactThomas Ach

Universitätsklinikum Bonn

thomas.ach@ukbonn.de+491703750772

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026